9 results
8-K
EX-99.2
LGVN
Longeveron Inc - Ordinary Shares
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
(58.3) n (%) Gender Male Female 47 (95.9) 2 (4.1) 9 (81.8) 2 (18.2) 13 (100) 0 13 (100) 0 12 (100) 0 n (%) Race White Black/African American 37 (75.5
DEF 14A
jcmt7qzo2q055gn2uqgp
13 May 22
Definitive proxy
4:10pm
8-K
EX-10.1
tby2paxtxfvge stn
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
S-1
EX-10.4
7nfn6v8io4h ff
19 Jan 21
IPO registration
5:21pm
DRS/A
EX-10.4
69kmdmy dxeesv4
30 Dec 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next